Does Statin Therapy Decrease the Risk for Bleeding in Patients Who Are Receiving Warfarin?

American Journal of Medicine

Volumn 120, Issue 4, 2007, Pages

  Douketis, James D ^a   Melo, Magda ^b   Bell, Chaim M ^b,c,d,e   Mamdani, Muhammad M ^b,c,e  

^a MCMASTER UNIVERSITY   (Canada)

^b INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d ST MICHAEL'S HOSPITAL   (Canada)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bleeding; Case control study; Oral anticoagulants; Statins

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIBIOTIC AGENT; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CERIVASTATIN; CIMETIDINE; CLOPIDOGREL; CORTICOSTEROID; CYCLOOXYGENASE 2 INHIBITOR; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; FLUCONAZOLE; FLUINDOSTATIN; LOSARTAN; MEVINOLIN; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; PRAVASTATIN; RIFAMPICIN; SIMVASTATIN; STEROID; TICLOPIDINE; TOLBUTAMIDE; UNINDEXED DRUG; WARFARIN;

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; CANADA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; DRUG EFFECT; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HOSPITALIZATION; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; ONSET AGE; POPULATION BASED CASE CONTROL STUDY; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; TREATMENT DURATION; UPPER GASTROINTESTINAL BLEEDING;

AGED; ATRIAL FIBRILLATION; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DRUG INTERACTIONS; FEMALE; HEMORRHAGE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MULTIVARIATE ANALYSIS; ONTARIO; RISK FACTORS; WARFARIN;

EID: 33947605463     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.008     Document Type: Article

References (28)

1. Briel M., Studer M., Glass T.R., and Bucher H.C. Effects of statins on stroke prevention in patients with and without coronary heart disease: a meta-analysis of randomized controlled trials. Am J Med 117 (2004) 596-606
2. Cheung B.M.Y., Lauder I.J., Lau C.-P., and Kumana C.R. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 57 (2003) 640-651
3. Tu J.V., and Gong Y. Trends in treatment and outcomes for acute stroke patients in Ontario, 1992-1998. Arch Intern Med 163 (2003) 293-297
4. Douketis J.D., Arneklev K., Goldhaber S.Z., et al. Ximelagatran versus warfarin: a comparison of bleeding outcomes in patients with nonvalvular atrial fibrillation. Arch Intern Med 166 (2006) 853-859
5. Szapary L., Horvath B., Marton Z., et al. Short-term effect of low-dose atorvastatin on haemorrheological parameters, platelet aggregation and endothelial function in patients with cerebrovascular disease and hyperlipidemia. CNS Drugs 18 (2004) 165-172
6. Undas A., Brummel K.E., Musial J., Mann K.G., and Szceklik A. Simvastatin depresses blood clotting by inhibiting activation of prothrombin, Factor V, and Factor XIII and by enhancing Factor Va inactivation. Circulation 103 (2001) 2248-2253
7. Juurlink D.N., Mamdani M., Kopp A., Laupacis A., and Redelmeier D.A. Drug-drug interactions among elderly patients hospitalized for drug toxicity. JAMA 289 (2003) 1652-1658
8. Ray J.G., and Mamdani M.M. Statins and the risk of idiopathic venous thromboembolism. Br J Clin Pharmacol 50 (2003) 460
9. Mamdani M.M., van Walraven C., Bica A., Williams J.I., and Naylor C.D. Is there an association between lipid-lowering drugs and cholecystectomy?. Am J Med 108 (2000) 418-421
10. Lubin J.H., and Gail M.H. Biased selection of controls for case-control analyses of cohort studies. Biometrics 40 (1984) 63-75
11. Langholz B. Case-control study, nested. In: Armitage P., and Colton C. (Eds). Encyclopedia of Biostatistics (1998), John Wiley & Sons Ltd, Chichester, England 514-519
12. Michalets E. Update: clinically significant cytochrome P-450 drug interactions. Pharmacotherapy 18 (1998) 84-112
13. Bravo G., Dubois M.F., Hebet R., De Wals P., and Messier L. A prospective evaluation of the Charlson Comorbidity Index for use in long-term care patients. J Am Geriatr Soc 50 (2002) 740-745
14. Schneeweiss S., Seeger J.D., Maclure M., Wang P.S., Avorn J., and Glynn R.J. Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data. Am J Epidemiol 154 (2001) 854-864
15. Banerjee S., Denniston A.K., Gibson J.M., and Dodson P.M. Does cardiovascular therapy affect the onset and recurrence of preretinal and vitreous haemorrhage in diabetic eye disease?. Eye 18 (2004) 821-825
16. Tseng M.-Y., Czosnyka M., Richards H., Pickard J.D., and Kirkpatrick P.J. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. Stroke 36 (2005) 1627-1632
17. Parra A., Kreiter K.T., Williams S., et al. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study. Neurosurgery 56 (2005) 476-484
18. Singhal A.B., Topcuoglu M.A., Dorer D.J., Ogilvy C.S., Carter B.S., and Koroshetz W.J. SSRI and statin use increases the risk for vasospasm after subarachnoid hemorrhage. Neurology 64 (2005) 1008-1013
19. Tirschwell D.L., and Longstreth Jr. W.T. Validating administrative data in stroke research. Stroke 33 (2002) 2465-2470
20. Rosamond W.D., Folsom A.R., Chambless L.E., et al. Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 30 (1999) 736-743
21. Leone M.A., Capponi A., Varrasi C., Tarletti R., and Monaco F. Accuracy of the ICD-9 codes for identifying TIA and stroke in an Italian automated database. Neurol Sci 25 (2004) 281-288
22. Broderick J., Brott T., Kothari R., et al. The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke 29 (1998) 415-421
23. Cattaruzzi C., Troncon M.G., Agostinis L., and Garcia Rodriguez L.A. Positive predictive value of ICD-9th codes for upper gastrointestinal bleeding and perforation in the Sistema Informativo Sanitario Regionale database. J Clin Epidemiol 52 (1999) 499-502
24. Raiford D.S., Perez G.S., and Garcia Rodriguez L.A. Positive predictive value of ICD-9 codes in the identification of cases of complicated peptic ulcer disease in the Saskatchewan hospital automated database. Epidemiology 7 (1996) 101-104
25. Cardiovascular Health and Services in Ontario: An ICES Atlas (1999), Institute for Clinical Evaluative Sciences, Toronto, Canada
26. Andrus M.R. Oral anticoagulant drug interactions with statins: case report of fluvastatin and review of the literature. Pharmacotherapy 24 (2004) 285-290
27. Kucher N., Connolly S., Beckman J.A., et al. International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med 164 (2004) 2176-2179
28. Fanikos J., Grasso-Correnti N., Shah R., Kucher N., and Goldhaber S.Z. Major bleeding complications in a specialized anticoagulation service. Am J Cardiol 96 (2005) 595-598